FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Nelarabine (Arranon) Injection
Status: Currently in Shortage
»Date first posted: 10/30/2018
»Therapeutic Categories: Hematology

Novartis (New 10/30/2018)

Company Contact Information:
888-669-6682

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/50 mL (NDC 0078-0683-06) Availability at wholesalers: All inventory has been depleted. Estimated Shortage Duration: TBD Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English